Abstract
The neural mechanisms underlying genetic risk for schizophrenia, a highly heritable psychiatric condition, are still under investigation. This study examines the association of two common neurogranin (NRGN) risk single nucleotide polymorphisms (SNPs) with functional and structural brain-based intermediate phenotypes. Using data from 92 schizophrenia patients and 114 healthy volunteers, researchers tested the association of NRGN SNPs rs12807809 and rs12541 with working memory-elicited dorsolateral prefrontal cortex (DLPFC) activity and cortical thickness. Results showed that rs12541 risk allele homozygotes (TT) displayed increased activity in several regions, including the left DLPFC and insula. Conversely, rs12807809 non-risk allele carriers showed reduced cortical thickness in the right occipital regions. These findings suggest that NRGN risk variants contribute to subtle changes in neural functioning and anatomy, providing a biological link between genetics and schizophrenia pathophysiology.
Introduction: Bridging the Genetic Gap
Schizophrenia is a complex, highly heritable disorder, yet the path from genetic risk to clinical symptoms remains poorly understood. While Genome-Wide Association Studies (GWAS) have identified numerous risk genes, they often fail to explain the underlying biological mechanisms. To address this, researchers focus on intermediate phenotypes—measurable traits like brain activity or structure that bridge the gap between DNA and behavior.
This study investigates the neurogranin (NRGN) gene, which is essential for synaptic plasticity and memory. Given the cognitive deficits characteristic of schizophrenia, NRGN is a primary candidate for influencing brain-based intermediate phenotypes.
Methodology
The researchers employed a multimodal approach using data from the Mind Clinical Imaging Consortium (MCIC), comprising 92 patients with schizophrenia and 114 healthy controls.
- Genotyping: Two specific SNPs within the NRGN gene, rs12807809 and rs12541, were analyzed.
- Functional Imaging (fMRI): Participants performed a working memory task (the Sternberg Item Recognition Paradigm) to measure activity in the Dorsolateral Prefrontal Cortex (DLPFC).
- Structural Imaging: Surface-based morphometry was used to assess cortical thickness and the volume of the Anterior Cingulate Cortex (ACC).
- Statistical Analysis: Associations between genotype and brain measures were tested using general linear models, adjusting for age, gender, and diagnosis.
Key Results and Discussion
Functional Impact: The Inefficiency Hypothesis
A primary finding was that carriers of the rs12541 risk allele (TT) exhibited significantly higher activity in the left DLPFC, left insula, and cingulate cortex during working memory tasks compared to non-risk carriers. In neuroimaging, this "over-activation" often indicates neural inefficiency—the brain must work harder to achieve the same level of cognitive performance.
This finding aligns with NRGN's role in the NMDA signaling pathway. Genetic variants may disrupt synaptic plasticity, leading to the "noisy" or inefficient signaling observed in the fMRI data.
Structural Impact
The study also identified structural differences associated with the rs12807809 variant. Interestingly, non-risk allele (C) carriers showed a 3.88% reduction in cortical thickness in the right pericalcarine gyrus and cuneus, as well as a 6.32% reduction in left rostral ACC volume. This "flip-flop" phenomenon—where a non-risk allele is associated with a typically "pathological" trait—suggests that the relationship between NRGN and brain structure is complex and may be influenced by other genetic or environmental factors.
Conclusion and Future Directions
This study highlights how common variants in the NRGN gene subtly alter brain function and anatomy. While the sample size is robust for neuroimaging, larger genetic studies are needed to confirm these associations across diverse populations. Future research should explore how NRGN interacts with other risk genes to better understand the cumulative genetic burden on brain health in schizophrenia.
Summary updated